State Street SPDR S&P Biotech ETF (XBI)
$146.80-3.04%Close
SELLBEAR · day 24
Key stats
ETF · income quality metrics
52-week IV22.7%–46.2%
- AUM
- $10.1B
- Expense
- 0.35%
- Yield
- 0.37%
- Quality
- 36
- Beta
- 1.12
- Max DD
- -63.89%
- 1Y
- +40.21%
- 3Y
- +104.83%
- 5Y
- +19.19%
- IV-%ile
- 77
- IV ATM
- 34.2%
- 1W
- -2.72%
- 1M
- -6.85%
- vs SPY 1W
- -2.58%
- vs SPY 1M
- -9.36%
Industry peers
FMP comparable companies · ranked by market cap
- AIQGlobal X - Artificial Intelligence & Technology ETF$11.4B$65.85
- BBUSJPMorgan BetaBuilders U.S. Equity ETF$8.9B$140.51
- EWZiShares MSCI Brazil ETF$8.6B$42.87
- TCAFT. Rowe Capital Appreciation Equity ETF$7.8B$43.55
- IDViShares International Select Dividend ETF$7.6B$42.15
- FDLFirst Trust Morningstar Dividend Leaders Index Fund$7.1B$50.28
- VOOVVanguard S&P 500 Value ETF$6.8B$225.91
- BBINJPMorgan BetaBuilders International Equity ETF$6.4B$77.65
- KBWBInvesco KBW Bank ETF$4.9B$86.77
- XARState Street SPDR S&P Aerospace & Defense ETF$3.8B$222.88
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on XBI?
- LOPJLB’s latest quantitative signal on State Street SPDR S&P Biotech ETF (XBI) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is XBI in?
- State Street SPDR S&P Biotech ETF (XBI) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does State Street SPDR S&P Biotech ETF (XBI) do?
- SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value s…